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James R. Hebert 4,5,6
Metabolic syndrome (MetS) is one of the risk factors for all causes of mortality. Inflammation 
is an important risk factor for MetS. The present cross-sectional study aimed to investigate the 
relationship between MetS and pro-inflammatory diet by using the food inflammation index (DII). 
This study consists of 10,017 participants with an age range of 35 to 70 years. The Fasa Cohort Study 
(FACS) population (Fars Province, Iran) was used to collect data. The DII was estimated according to 
Shivappa et al. method using a validated 125-item FFQ. To determine the association between MetS 
components and DII Logistic regression was used (P > 0.05). The overall mean of DII was − 0.89 ± 1.74. 
However, adjusted multinomial logistic regression indicates each unit increase in waist circumference 
(WC) (OR 0.98, 95% CI 0.96–0.99) and HDL-C (OR 0.99, 95% CI 0.98–0.99) was associated with 
significantly decreased odds of being in the 4th DII quartile in men and all participations respectively, 
there is no statistically significant relationship between MetS and DII. Overall, although people in the 
highest quartile of inflammatory food consumption had more likely to develop MetS, this relationship 
was not statistically significant among males and females.
Metabolic syndrome (MetS) is one of the risk factors for type 2 diabetes, cardiovascular  disease1, all causes of 
 mortality2, and a major public health problem  worldwide3. In addition to the main components of MetS, includ-
ing abdominal obesity, dyslipidemia, hyperglycemia, hypertension, and high-density lipoprotein cholesterol 
(HDL-C) level  decrease4, other disorders such as non-alcoholic fatty liver (NAFLD) appear to be a part of the 
 syndrome5. Studies have shown that MetS is widely prevalent in Middle Eastern countries, including  Iran5. 
According to recent studies, the prevalence of MetS in Iran is estimated to be 36.5%6. Also, non-communicable 
diseases, including MetS, account for a high proportion of deaths in Iran, rising from 57% in 1999 to 76% in 
 20107.
Although the exact pathology of the MetS is not clear, it seems that genetic background, lifestyle, environmen-
tal factors such as dietary habits, physical inactivity, aging, and body mass index (BMI) are important factors in 
this  regard8. Additionally, studies have shown that inflammation also is a risk factor for  MetS5,9–11. Obesity also 
increases the inflammatory factors that are the underlying causes of  MetS9,12.
Inflammation is a natural physiological response to cellular damage and a variety of environmental  stimuli13. 
In addition to MetS, inflammation is involved in the pathophysiology of many chronic diseases such as obesity, 
diabetes, cancer, and cardiovascular  disease13,14. Exposure to chronic stress, on the other hand, leads to low-grade 
inflammation, which may also play a role in the development of  MetS15. Although many factors such as age, sex, 
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physical activity, cigarette, and diet play important roles in the development of inflammation, the role of the 
diet is more evident and well  researched15,16. Furthermore, studies show that the overall dietary composition for 
predicting the risk of chronic illness and death is much more important than individual nutrients  alone17. For 
instance, some diets such as the Mediterranean diet, which is rich in fruits, olive oil, vitamins, and antioxidants, 
reduce inflammation, and  MetS18. In contrast, Western diets, which are rich in a variety of saturated and ω-6 
fatty acids and simple carbohydrates, cause the most inflammation among all existing  diets12.
The Dietary Inflammatory Index (DII) is used to evaluate the anti and pro-inflammatory properties of the 
diet in different  individuals19. The index was developed in 2009 and updated again in  201419. So far, more than 
200 articles have used this  index20. It is assumed that the consequences of inflammation can be predicted by this 
index in virtually any  population5. This index is designed to assess the inflammatory potential of a diet based 
on the inflammatory and anti-inflammatory properties of various food components, such as macronutrients, 
vitamins, minerals, flavonoids, alcohol, and other specific nutritional  compounds21. It has been reported that the 
use of this index is very effective in evaluating the level of dietary  inflammation16. Although various studies in 
different populations show inconsistent and even non-significant results regarding the DII concerning  Mets22–24, 
many studies have reported a significant relationship between MetS or its components and DII to  score5,21,23,25,26. 
A recent meta-analysis and systematic review reported that despite the lack of a consistent significant relation 
between the pro-inflammatory diet and MetS, there is a very strong relationship between the DII and cardiovas-
cular disease (CVD) risk, which is an important sequel of MetS and type II diabetes  mellitus27.
Based on our knowledge, although a few studies have been done in this regard in Iran, none of them had the 
same sample size as in our study (10,017 participants). Accordingly, it has been recommended that sample sizes 
be increased to assess the role of the inflammatory potential of diet associated with MetS and assist policymakers 
in promoting population  health28. Therefore, the current cross-sectional study was conducted using data of a 
cohort study in Fasa (Fars Province, Iran) to examine the relationship between MetS and DII.
Results
The 10,017 participants had a mean age of 48.64 ± 9.56 years. There were 5499 (54.9%) females and 4518 (45.1%) 
males enrolled in the current study. Based on BMI, 40.7% of participants were categorized in the normal category, 
36.1% were overweight and 17.5% were obese (Table 1). Although the overall proportion of smokers was 27.1%, 
the proportion of male smokers was significantly higher than females (54.0% vs. 5.1%, P < 0.001). Moreover, the 
overall mean of DII was − 0.89 ± 1.74 which was − 1.33 ± 1.62 and − 0.53 ± 1.76 for males and females respectively 
(Table 1).
Results of logistic regression showed that, after adjusting for BMI and age, being in the 3rd or 4th DII quartile 
was associated with significantly increased odds of MetS (OR 1.20 and 1.37 respectively). Also, among MetS 
components, DII quartiles were most strongly associated with waist circumference (WC) (Table 2).
As shown in Table 3, although in the unadjusted linear regression model almost all MetS components (except 
fasting plasma glucose (FPG) in women and men) had a significant relationship with DII, in the adjusted model 
this relationship only was observed in diastolic blood pressure (DBP), HDL-C and low-density lipoprotein 
cholesterol (LDL-C) in men and WC, DBP, triglyceride (TG) and HDL-C in women.
To investigate the effect of each unit increase in metabolic syndrome components on odds of belonging into 
the 2nd, 3rd, or 4th quartile of DII, multinomial logistic regression was implemented, and results separately were 
summarized in Table 4. Models adjusted for sex, smoking status, and BMI revealed that each unit increase in WC 
leads to significantly decrease odds of belonging into the 4th quartile of DII in men (OR 0.98, 95% CI 0.96–0.99). 
Besides, each unit increase in HDL-C was associated with significantly decreased odds of being in the 4th DII 
quartile in males and females (OR 0.99, 95% CI 0.98–0.99). It is important to note that these factors marginally 
were significant. Besides, although the odds ratio (OR) of MetS among all patients in the 4th DII quartile was 
higher than others, this relationship was not statistically significant among males and females.
Discussion and conclusion
In this cross-sectional study, we review the relationship between MetS and DII in rural populations that registered 
in the Fasa Cohort study (FACS) at Fasa University of Medical Sciences (FUMS). In general, the multinomial 
logistic regression test shows that people in the highest quartile of inflammatory food consumption, which their 
dietary habits have the highest level of inflammation risk, are 1.24 and 1.09 times in men and women more likely 
to develop MetS, which decreases to 1.20 and 1.01 times by adjusting the variables in males and females respec-
tively. These levels are not statistically significant in the present population. Also, the present study showed that 
men at the highest risk of food inflammation (after adjusting variables) were 0.98 times less likely to be in the 
group with high levels of WC. We also observed that both males and females the highest risk of DII were 0.99 
times less likely to be in the group with high levels of HDL-C. According to Table 4, these results are marginally 
significant. Other factors related to MetS such as blood pressure, FPG, and TG did not show significant results 
in any gender.
As noted above, DII is a dietary tool used to evaluate the inflammatory potential of individual  diets19. This 
index is a useful tool to predict the level of inflammatory cytokines such as IL6, CRP, and health indices based on 
the score of dietary  inflammation29. Studies have shown that higher levels of DII maybe correlate with elevated 
levels of serum inflammatory factors such as IL-6, CRP, fibrinogen, homocysteine, TNF-α13,19,23,30, and white 
blood cell count (WBC)31. In this regard, several studies have reported a significant relationship between diet and 
inflammatory  factor32. However, some studies have shown contrary  results33. Overall, it can be concluded that the 
nutritional approach can affect the immune response by reducing (or increasing) the rate of these inflammatory 
 indices34 and, consequently, lead to the developing or declining incidence of the MetS.
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In the present study, an increase in DII score quartiles led to a subsequent rise in odds ratio (ORs) of MetS, 
but multinomial logistic regression showed that this relationship was not statistically significant among both 
sexes (Table 4). However, Table 2 shows that after adjusting the variables of age and BMI, this level is significant 
in the third and fourth quartiles. Other studies show that diets that contain high fats (particularly, saturated 
and trans fats) and simple carbohydrates or sugar, and a small amount of fiber and omega-3 fatty acids, tend 
to increase the incidence of non-communication and inflammatory diseases, including  MetS35. Nevertheless, 
recent DII studies on the relations between the status of dietary inflammation and various diseases have shown 
that DII is an appropriate tool for assessing the level of dietary  inflammation16,19. The results of this study are not 
consistent with studies that indicate a significant relationship between MetS and  DII5,21,24,36. In this regard, the 
results of Spanish cohort studies (n = 6851, 8.3 years)37, the cross-sectional studies of Poland-Norway (n = 3862)22, 
Luxembourg (n = 1352)25, Lebanon (n = 331)10, and the study conducted by American police officers (n = 464)23 
are consistent with the present study. Finally, a meta-analysis study that examined 17 papers in 2017 reported a 
lack of any significant correlation between DII and the risk of developing MetS. This study indicates that although 
the most inflammatory diet, compared to the anti-inflammatory diet, increases the risk of CVD by up to 35%, 
the risk of developing MetS does not  increase27. The study also showed that despite the lack of any significant 
relationship between MetS and DII based on the meta-analysis, there was a significant relationship between DII 
and other subsets of MetS in some  studies27.
These differences can be due to the type and design of the study, the target population, race, the number 
of participants in each study, and how to assess the diet, the type and the number of existing nutrients in the 
calculation of DII, and the exposure duration of each subset to inflammation. The results of the present study 
Table 1.  Basic characteristics of the study participants. BMI body mass index, WC waist circumference, 
HDL-C High-density lipoprotein cholesterol, SBP systolic blood pressure, DBP diastolic blood pressure, WBC 
white blood cell, FPG fasting plasma glucose, BUN blood urea nitrogen, Cr creatinine, TG triglyceride, TC total 
cholesterol, LDL-C low-density lipoprotein cholesterol, SGOT serum glutamic-oxaloacetic transaminase, SGPT 
serum glutamic-pyruvic transaminase, ALP alkaline phosphatase, GGT gamma-glutamyl transferase, DII 
Dietary Inflammatory Index.
Variable
Male (n = 4518) Female (n = 5499) Total (n = 10,017)
Number Percent Number Percent Number Percent
Age group (years)
< 40 962 21.3 1200 21.8 2162 21.6
40–50 1616 35.8 1894 34.4 3510 35.0
50–60 1216 26.9 1518 27.6 2734 27.3
> 60 724 16.0 887 16.1 1611 16.1
BMI group (kg/m2)
< 18.5 424 9.4 145 2.6 569 5.7
18.5–24.99 2220 49.1 1859 33.8 4079 40.7
25.0–29.99 1457 32.2 2162 39.3 3619 36.1
> 30.0 417 9.2 1333 24.2 1750 17.5
Smoking status
No 2077 46.0 5221 94.9 7298 72.9
Yes 2441 54.0 278 5.1 2719 27.1
Mean SD Mean SD Mean SD
Age (years) 48.63 9.60 48.64 9.53 48.64 9.56
WC (cm) 89.52 11.18 96.13 11.47 93.15 11.81
SBP (mmHg) 110.53 17.68 112.07 19.31 111.37 18.60
DBP (mmHg) 74.34 11.90 74.89 12.17 74.65 12.05
WBC (10^3/µL) 6.55 1.83 6.37 1.69 6.45 1.76
FPG (mg/dl) 90.18 24.22 94.58 33.03 92.59 29.47
BUN (mg/dl) 13.74 3.95 12.29 3.84 12.95 3.95
Cr (mg/dl) 1.06 0.18 0.92 0.18 0.98 0.19
TG (mg/dl) 136.16 91.34 128.28 74.19 131.83 82.46
TC (mg/dl) 178.79 37.96 190.27 39.42 185.09 39.18
HDL-C (mg/dl) 47.24 14.41 54.14 16.39 51.03 15.90
LDL-C (mg/dl) 104.25 31.78 110.44 33.58 107.65 32.92
SGOT (UL/L) 23.85 8.41 21.52 8.43 22.57 8.50
SGPT (UL/L) 26.08 16.52 21.28 12.01 23.44 14.42
ALP (U/L) 211.07 65.56 208.21 75.51 209.50 71.20
GGT (mg/dl) 25.81 22.54 20.42 20.04 22.85 21.37
DII − 1.33 1.62 − 0.53 1.76 − 0.89 1.74
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Table 2.  Odds of metabolic syndrome and its component by DII normal quartiles. Adjusted for BMI and age. 
HDL-C high-density lipoprotein cholesterol, FPG fasting plasma glucose.
DII quartile Present Absent Crude OR (95% CI) Adjusted OR (95% CI)
Metabolic syndrome
1 522 (23.5) 1982 (25.4) 1.00 (reference) 1.00 (reference)
2 519 (23.4) 1985 (25.5) 0.99 (0.87–1.14) 1.03 (0.89–1.20)
3 549 (24.7) 1956 (25.1) 1.07 (0.93–1.22) 1.20 (1.03–1.39)
4 629 (28.3) 1875 (24.0) 1.27 (1.12–1.45) 1.37 (1.18–1.59)
Waist component
1 1013 (22.7) 1491 (26.9) 1.00 (reference) 1.00 (reference)
2 1096 (24.5) 1408 (25.4) 1.15 (1.02–1.28) 1.43 (1.23–1.66)
3 1129 (25.3) 1376 (24.8) 1.21 (1.08–1.35) 1.95 (1.67–2.27)
4 1227 (27.5) 1277 (23.0) 1.41 (1.26–1.58) 2.70 (2.31–3.16)
Blood pressure component
1 536 (23.1) 1968 (25.6) 1.00 (reference) 1.00 (reference)
2 538 (23.2) 1966 (25.6) 1.01 (0.88–1.15) 1.00 (0.86–1.15)
3 564 (24.3) 1941 (25.2) 1.07 (0.93–1.22) 1.10 (0.95–1.27)
4 685 (29.5) 1819 (23.6) 1.38 (1.21–1.57) 1.28 (1.11–1.47)
HDL-C component
1 1013 (24.0) 1491 (25.7) 1.00 (reference) 1.00 (reference)
2 1022 (24.2) 1482 (25.5) 1.02 (0.91–1.14) 1.04 (0.93–1.17)
3 1071 (25.4) 1434 (24.7) 1.10 (0.98–1.23) 1.16 (1.03–1.30)
4 1110 (26.3) 1394 (24.0) 1.17 (1.05–1.31) 1.29 (1.15–1.44)
Triglyceride component
1 790 (28.0) 1714 (23.8) 1.00 (reference) 1.00 (reference)
2 727 (25.8) 1777 (24.7) 0.89 (0.79–1.00) 0.90 (0.80–1.02)
3 668 (23.7) 1837 (25.5) 0.79 (0.70–0.89) 0.83 (0.73–0.94)
4 637 (22.6) 1867 (25.9) 0.74 (0.65–0.84) 0.77 (0.68–0.88)
FPG component
1 452 (23.6) 2052 (25.3) 1.00 (reference) 1.00 (reference)
2 436 (22.7) 2068 (25.5) 0.96 (0.83–1.11) 0.94 (0.81–1.10)
3 488 (25.4) 2017 (24.9) 1.10 (0.95–1.27) 1.13 (0.97–1.31)
4 543 (28.3) 1961 (24.2) 1.26 (1.09–1.44) 1.16 (1.00–1.34)
Table 3.  Results of linear regression for the association between DII as a response variable and metabolic 
syndrome components. WC waist circumference, HDL-C high-density lipoprotein cholesterol, SBP systolic 
blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TG triglyceride, LDL-C low-density 
lipoprotein cholesterol.
Subgroup Variables
Model 1 (unadjusted)
Model 2 (adjusted by smoking status, BMI, 
glucose-lowering medication, and hypertension 
medications use)
Coefficient Standardized coefficient P value Coefficient Standardized coefficient P value
Male
WC − 0.022 0.002 < 0.001 − 0.009 0.005 0.05
SBP 0.008 0.002 < 0.001 0.004 0.002 0.10
DBP − 0.013 0.003 < 0.001 − 0.008 0.003 0.01
FPG − 0.001 0.001 0.43 − 0.002 0.001 0.14
TG − 0.001 < 0.001 < 0.001 0.001 < 0.001 0.13
HDL-C − 0.006 0.002 < 0.001 − 0.007 0.002 < 0.001
LDL-C 0.001 0.001 0.04 0.002 0.001 0.03
Female
WC − 0.17 0.002 < 0.001 − 0.012 0.004 0.01
SBP 0.012 0.002 < 0.001 0.002 0.002 0.31
DBP − 0.014 0.003 < 0.001 − 0.008 0.003 0.02
FPG 0.001 0.001 0.12 0.001 0.003 0.61
TG − 0.001 < 0.001 < 0.001 − 0.001 < 0.001 < 0.001
HDL-C − 0.008 0.001 < 0.001 − 0.008 0.001 < 0.001
LDL-C 0.002 0.001 0.02 0.001 0.001 0.13
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are more reliable than those of previous studies because it was conducted in a cross-sectional design with more 
target population (n = 10,017). On the other hand, some studies that have reported a significant relationship 
between these factors emphasize that their results are marginally significant and these results should be inter-
preted with  caution21. The sex and age differences of the samples can also be an effective factor in the results of 
 study24. According to a  study22, although there is a significant positive relationship between DII and MetS in 
women, this relationship is not significant in men.
The relation between MetS and DII may be related to dietary  pattern5. Various studies have shown the associa-
tion of dietary patterns with various diseases, including  cancer38,  obesity39, diabetes, and MetS. Moreover, it has 
been reported that the DII score in some diets, including DASH (Dietary Approach to Stop Hypertension), HEI-
2010 (Healthy Eating Index-2010), and AHEI (Alternate Healthy Eating Index), is  positive40. In line with these 
results, a meta-analysis study showed a significant relationship between MDS (The Mediterranean Diet Score) 
score and a decrease in blood pressure and TG and an increase in HDL-C18. DII score is a specific feature of the 
existing  diet21. The correlation between DII and MetS scores relies on the compounds and nutrients that every 
person consumes during the day, week, or month. In other words, this is the same quality of food consumed by 
a person and, since this quality varies in different countries, it leads to contradictory results. Another important 
factor in this context is the number of items used in the FFQ questionnaire or food intake measurement tools, 
which varies from previous studies and thus leads to different conclusions. Moreover, previous studies have used 
55-item22, 36-item21, and 23-item24 24-h recalls, but we utilized the 125-item FFQ with daily, weekly, monthly, 
and yearly recalls. In this connection, one meta-analytic study also states that the use of FFQ is much more 
accurate than 24-h dietary  recall27. Filling out questionnaires in face-to-face interviews provides more accurate 
information rather than self-reporting27. Therefore, all questionnaires of this study, contrary to some previous 
 studies37, have been completed in face-to-face interviews by trained people to minimize the bias of the results.
In the present study, different results were obtained in evaluating the relationship between various param-
eters of the MetS and the DII, some of which were different and even contradictory in different analyses. For 
example, WC in the second, third, and fourth quartiles showed a significant positive relationship with the MetS 
in Table 2. In the adjusted model of a linear regression test, after modulating the variables, this parameter along 
with HDL-C, DBP, and TG had a significant relationship with DII in women. Finally, multinomial logistic 
regression showed that by increasing each unit in waist size, the chance of being in the fourth quarter of DII was 
significantly reduced in men. Neufcourt et al. reported that there was no significant relationship between WC 
and  DII21, which was inconsistent with the results of the present study. On the other hand, some studies have 
shown contradictory  results22,25,26. The relationship between WC and DII can be interpreted as follows; Since 
the WC measures abdominal obesity, it can have an important role in the prediction of inflammatory  factors41. 
Also, since the WC and abdominal obesity are different in men and women, as well as in different populations, 
and have different measurement criteria, this may be an important cause of contradiction in the results. In line 
with this statement, even some studies suggest that there is a direct relationship between DII and abdominal 
Table 4.  Results of multinomial logistic regression about the effect of each unit increase in metabolic 
syndrome components on odds of belonging into the 2nd, 3rd or 4th quartile of DII. WC waist circumference, 
SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TG triglyceride, HDL-C 
high-density lipoprotein cholesterol.
Variable
Model 1 (unadjusted) Model 2 (adjusted by smoking status and BMI)
DII normal DII normal
Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Male
Metabolic 
syndrome 1 1.03 (0.78–1.38) 1.15 (0.84–1.57) 1.24 (0.87–1.79) 1 1.02 (0.76–1.35) 1.16 (0.85–1.59) 1.20 (0.83–1.73)
WC 1 0.99 (0.98–1.00) 0.98 (0.97–0.99) 0.96 (0.95–0.97) 1 0.99 (0.98–1.01) 0.99 (0.98–1.01) 0.98 (0.96–0.99)
SBP 1 1.01 (1.00–1.02) 1.00 (0.99–1.01) 1.02 (1.01–1.03) 1 1.01 (1.00–1.02) 1.00 (1.00–1.01) 1.01 (1.00–1.02)
DBP 1 0.98 (0.97–0.99) 0.99 (0.98–1.00) 0.97 (0.96–0.99) 1 0.99 (0.98–1.00) 0.99 (0.98–1.00) 0.98 (0.97–1.00)
FPG 1 0.99 (0.99–1.00) 1.00 (1.00–1.00) 1.00 (0.99–1.00) 1 0.99 (0.99–1.00) 1.00 (0.99–1.00) 1.00 (0.99–1.00)
TG 1 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00)
HDL-C 1 0.99 (0.99–1.00) 0.99 (0.99–1.00) 0.99 (0.98–0.99) 1 0.99 (0.99–1.00) 0.99 (0.99–1.00) 0.99 (0.98–0.99)
Female
Metabolic 
syndrome 1 0.89 (0.71–1.12) 0.97 (0.78–1.21) 1.09 (0.88–1.35) 1 0.88 (0.70–1.11) 0.94 (0.75–1.17) 1.01 (0.81–1.26)
WC 1 0.99 (0.98–1.00) 0.98 (0.98–0.99) 0.97 (0.97–0.98) 1 0.99 (0.98–1.01) 0.99 (0.98–1.01) 0.98 (0.97–1.00)
SBP 1 1.00 (1.00–1.01) 1.01 (1.01–1.02) 1.02 (1.01–1.02) 1 1.00 (0.99–1.01) 1.00 (1.00–1.01) 1.01 (1.00–1.01)
DBP 1 0.99 (0.98–1.01) 0.99 (0.97–1.00) 0.98 (0.97–0.99) 1 0.99 (0.98–1.01) 0.99 (0.98–1.00) 0.99 (0.98–1.00)
FPG 1 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00)
TG 1 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1 1.00 (1.00–1.00) 1.00 (1.00–1.00) 1.00 (1.00–1.00)
HDL-C 1 0.99 (0.99–1.00) 0.99 (0.99–1.00) 0.99 (0.98–0.99) 1 0.99 (0.99–1.00) 0.99 (0.99–1.00) 0.99 (0.98–0.99)
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obesity in women; however, this relationship is not statistically significant for  men24. Hence, it seems that this 
issue needs further studies.
In the present study, there was a significant relationship between the increase in FPG and DII in Table 2 (in 
the fourth quartile). However, after adjusting the variables, none of the linear and multinomial regression tests 
showed a significant relationship among men and women. Unlike some other studies, those from  Luxemburg25 
and  France21 reported results consistent with the present study. Meanwhile, Nikniaz et al. found a statistically 
significant relationship between these two parameters in the Iranian  population5, which is not consistent with 
the results of the present study. Moreover, the results of the present study are not in line with those reported by 
Wirth et al. on police officers in the United  States23. In a Korean study, there was a significant relation between 
DII and hyperglycemia only in men, while such a relationship was not found in postmenopausal  women24. It 
seems that this issue needs further research.
In this cross-sectional study, there was a significant positive correlation between blood pressure and DII in 
Table 2 in the fourth quartile. Also, in the adjusted linear regression test, DBP was one of the factors that had 
a significant correlation with DII both in males and females. However, there was no significant relationship 
between these parameters in the adjusted multinomial logistic regression test. In this regard, the results of some 
studies are inconsistent with those of the present  study21,26. It is assumed that inflammation negatively affects 
the blood vessels and the kidneys and increases blood  pressure42. Blood pressure, as a multifactorial disease, 
can be controlled by considering other factors such as environmental factors and stress. The present study and 
other mentioned studies have not paid attention to this point, which may explain the difference in the results. 
However, more studies are needed to conclude on this issue.
In our study, there was a significant inverse correlation between DII and HDL-C and TG levels in Table 2 
(in the third and fourth quartiles). However, the adjusted multinomial logistic regression showed that each unit 
increase in HDL-C was associated with significantly decreased odds of being in the 4th DII quartile in both sexes. 
It is of note that in the adjusted linear regression test, the HDL-C level was among the factors that had a signifi-
cant correlation with DII both men and women. Besides, TG had a significant relationship with DII in males. 
However, the findings of some studies were not consistent with those of the present  study21,26. Meanwhile, a study 
on 1352 people in Luxembourg reported a significant inverse relationship between the score obtained from DII 
and the increase in HDL-C  levels33, which are not consistent with the results of the present study. The  French21 
and the  SUVIMAX37 studies also yielded results similar to those of the Luxembourg study. Although in this 
study the dietary patterns and anthropometric factors have been used to assess DII, we should not ignore other 
factors contributing to the increase of the fat profile, such as inactivity and the type and amount of consumed oil.
The limitations of this study are as follows: first, in this study, the dietary assessment was based on the self-
reporting data and the individual’s memory, and the possibility of error in the self-reporting questionnaire was 
high. To minimize this problem, all questionnaires were filled out by trained people. Second, this study was 
conducted in a rural area of Fasa. Thus, in other geographic areas in Iran or other countries with different dietary 
patterns, different results would be obtained. Accordingly, generalizing the results of this study to other popula-
tions should be done cautiously. Third, in the present study, only the dietary pattern and DII were emphasized 
and other parameters such as stress and environmental factors that produce inflammatory  factors43 were not 
studied. And finally, in this study, only the correlation between the components of MetS and DII was evaluated 
and the inflammatory factors were not studied separately. Therefore, this issue should be taken into account in 
future studies. The other weakness of the present study is that due to the type of study (cross-sectional nature), 
the causal relationship cannot be derived from the present study.
One of the strengths of the present study is the study design and the sample size. None of the previous stud-
ies had a sample size as much as our samples. Also, all previous studies suggested a larger sample size to better 
understand the relationship between MetS and DII. The present study has all of these features. Another strength 
of our study is that unlike most previous studies that have used 24-h recalls, in the present study, a 125-item FFQ 
was used, which is more reliable for dietary pattern assessment. Moreover, all anti-inflammatory foods such as 
garlic, onions, and spices (e.g., turmeric, saffron, and pepper) were included in this list. Another noteworthy 
point of this study is that it was conducted by the experts and trained interviewers and all clinical data and tests 
were carefully recorded. Moreover, the data were recorded electronically for further research on the website 
ncdrc.fums.ac.ir/collaboration.
To summarize, however, some components of MetS such as DBP, HDL-C, and LDL-C in men and WC, DBP, 
TG, and HDL-C in women (according to adjusted linear regression) had a significant relationship with DII and 
also men and all participation at the highest risk of food inflammation (after adjusting variables in multinomial 
regression) were marginally less likely to be in the group with high levels of WC and HDL-C respectively, our 
results lack any significant correlation between DII and the risk of developing MetS among males and females 
(base on adjusted multinomial regression). It seems that to better understand this issue, further analysis on the 
relationship between MetS and DII in other populations is necessary.
Materials and methods
The Fasa PERSIAN Cohort study (FACS) population was used to collect data for this study. FACS is a longitudinal 
study designed to assess the risk factors of non-communicable diseases (NCDs) in Sheshdeh rural district and 
its 24 surrounding villages (in Fasa County, Iran)28. It also is a part of the Prospective Epidemiological Research 
Studies (PERSIAN) in  Iran44. A total of 10,017 people aged 35–70 years of Fars, Turk, and Arab ethnicities were 
recruited into the cohort. People were invited to participate in this study by healthcare experts working in the 
rural health system. In fact, in Iran, these healthcare experts are called  Behvarzes45. These experts provide primary 
health care in small villages and towns. They are residents of the region who are trusted and selected 2 work in 
the health network of Iran after participating in special courses. This course lasts 2 years and during this time 
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all primary health care and basic physical checkups such as blood pressure control are taught. The experts have 
an important role in the healthcare system of Iran, and each of them works for a population of 200–2000 indi-
viduals at rural health centers. It is noteworthy that before the beginning of the study, all experts participated in 
the training classes and were fully acquainted with the study protocol, objectives and sampling method. Finally, 
after counting the households in their district, the experts selected all eligible individuals in each household and 
invited them to study. The households were selected in a clockwise manner, with the health center as the start-
ing point. In this manner, the health house was selected as the origin and Behvarzes chose every living place for 
inviting each qualified habitant of the area in a clockwise.
It is important to note that the study protocol was set following the Declaration of Helsinki guidelines and 
was approved by the Institutional Review Board (IRB) of Fasa University of Medical Sciences (Code: IR.FUMS.
REC.1395.177). Written informed consent was obtained from all the participants. Besides, it was confirmed that 
all the methods were performed following the relevant guidelines and regulations.
Target area and population. The city of Fasa is located in the eastern part of Fars province, in southwest-
ern Iran. According to the latest population census, the city has a population of about 250,000. The rural area 
of Sheshdeh with a population of about 41,000 was selected from all surrounding villages of Fasa County. A 
population with an age range of 35 to 70 years was chosen as the target population for participation in this study. 
The main reason for selecting this population is that this demographic group, on one hand, is old enough to be 
exposed to health problems and risk factors for non-communicable diseases and, on the other hand, it is young 
enough that the final complications of CVD and other NCDs, including MetS, have not yet occurred.
Management office, sampling, and laboratory. In the present study, an office was provided in Shesh-
deh and at the main health center of the region for sampling and interviewing the participants. Also, computers 
and the equipment needed for the interview and sampling were provided. The study laboratory was located at 
the Center for Research on NCDs in Fasa University of Medical Sciences (FUMS).
Human resources. A team of supervisors, two physicians, interviewers, nurses, blood sampling techni-
cians, a driver, and a guard were working at the office daily. The duty of the supervisor was monitoring and per-
forming sampling based on the protocol. All team members were selected from among volunteers and recruited 
after passing special courses. The interviewers were trained to complete the questionnaires of the participants in 
the form of a standard digital questionnaire and screening tool, based on the participants’ answers. To increase 
efficiency, according to the questionnaire type, the interviewers were divided into two groups: public informa-
tion and nutrition information groups.
The study procedure. Initially, the registration began with the national ID registration (IDID), and then a 
proprietary code (PCID) was given to each participant. To identify the individuals, they were asked to use this 
code in questionnaires and forms until the end of the research. Before starting the research, the written informed 
consent form was signed by all participants. In the next step, height, weight, and body composition were meas-
ured using BIA [(Bioelectrical impedance analysis (Tanita BC-418, Japan)] for all participants and BMI was 
calculated by dividing the weight by height squared. Also, the WC of all participants was measured. Then, blood 
pressure was measured by a trained nurse after a 15-min rest in a sitting position (sphygmomanometer, mercury, 
ALPK1, Japan). For accuracy, this evaluation was repeated after 15 min and the mean of both measurements was 
reported as the blood pressure of each subject.
Next, after a 10–14-h overnight fast, a 20 ml blood sample was obtained from each participant, and these 
were stored in encoded tubes after sampling. Afterward, tubes were referred to a laboratory of NCDs to per-
form relevant tests [WBC, FPG, Blood urea nitrogen (BUN), Creatinine (Cr), TG, total cholesterol (TC), serum 
glutamic-oxaloacetic transaminase (SGOT), Serum glutamic-pyruvic transaminase (SGPT), alkaline phosphatase 
(ALP), HDL-C, gamma-glutamyl transferase (GGT)]. All tests (including FPG) were done after at least 10 h of 
fasting and were measured by Pars Azmoon kits (Pars Azmoon Co., Tehran, Iran).
FPG was measured by using the glucose oxidase method, GGT by enzymatic method base on SZASZ’s 
approach, and SGOT, SGPT, and ALP by the kinetic method. BUN concentration was determined according to 
the manufacturer’s instructions and Serum Cr was measured by Jaffe’s method. HDL-C, TG, and total choles-
terol levels were also determined by the enzymatic method and were recorded in mg/dl. Besides, the Friedewald 
formula (FF) was used to assess LDL-C46.
According to the definition of the National Cholesterol Education Program’s Adult Treatment Panel (ATP) 
III, if the person has 3 following conditions were considered as the MetS: TG ≥ 150 mg/dl, HDL-C < 40 mg/dl for 
male, and < 50 mg/dl for females, FPG > 100, systolic blood pressure (SBP) > 130 mmHg and/or DBP > 85 mmHg, 
and WC > 88 cm for women or WC > 102 cm for  men47.
Interview to fill out the questionnaire. As previously mentioned, this stage was divided into two parts. 
In the general questionnaire, the demographic information of the participants was recorded. This part includes 
personal information, socioeconomic status, occupational status, residence, lifestyle, smoking, anthropometric 
measurements.
A 125-item Food Frequency Questionnaire (FFQ) based on the Willett-type questionnaire with necessary 
changes made based on the Iranian food regime was used to assess the dietary habits and type of food consumed 
by participants in the last year. People were asked to report the frequency and amount of each food on the list 
(Iranian foods) on a daily, weekly, monthly, and annual bases over the past year. The standard size of each food 
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is based on the USDA (United States Department of Agriculture) values More details are available at ncdrc.fums.
ac.ir/collaboration)28.
How to fill out and scoring the DII questionnaire. Dietary Inflammatory Index (DII) scores were 
calculated according to Shivappa et al., the complete description of which is available  elsewhere19. The DII was 
based on determining which food parameters were documents in the peer-reviewed literature to have affected 
at least one of 6 inflammatory factors (a significant increase in IL-1β, IL-6, TNF-α, and CRP or a significant 
decrease in IL-4 or IL-10)19. A total of 45 food parameters were identified in a literature search of 1943 articles. A 
score of + 1 was assigned to a positive association with a pro-inflammatory biomarker or a negative association 
with an anti-inflammatory biomarker. A score of -1 was assigned to a negative association with a pro-inflam-
matory biomarker or a positive association with an anti-inflammatory biomarker. A zero score was assigned to 
all null  results19. A Z-score was calculated and transformed into a centered percentile score. The DII score was 
multiplied by the overall score of the food parameter to obtain a specific score of the food parameter. Finally, 
the E-DII score of each person was calculated by summing all the specific scores of the food parameters. As for 
the individual scores, positive and negative overall DII/E-DII scores represent the pro-inflammatory and anti-
inflammatory dietary patterns, respectively.
In the present study, the average daily intake of 125 food parameters was measured using a validated Quan-
titative Food Frequency Questionnaire (FFQ). The food parameters calculated in the present study are as follow.
Alcohol (g), Vitamin B12 (ug), Vitamin B6 (mg), Beta Carotene (ug), Caffeine (g), Carbohydrate (g), Cho-
lesterol (mg), Energy (kcal), Eugenol (mg), Total Fat (g), Fiber (g), Folic Acid (ug), Garlic (g), Ginger (g), Iron 
(mg), Magnesium (mg), MUFA (g), Niacin (mg), Omega 3 (g), Omega 6 (g), Onion (g), Protein (g), PUFA (g), 
Riboflavin (mg), Saffron (g), Saturated Fat (g), Selenium (ug), Thiamin (mg), Trans Fat (g), Turmeric (mg), 
Vitamin A (RE), Vitamin C (mg), Vitamin D (ug), Vitamin E (mg), Zinc (mg), Green tea/Black tea (g), Flavan-
3-ol (mg), Flavones (mg), Flavonols (mg), Flavonones (mg), Anthocyanidins (mg), Isoflavones (mg), Pepper (g), 
Thyme/Oregano (mg), Rosemary (mg).
Statistical methods. Descriptive statistics for quantitative variables were reported as number (%) and for 
quantitative variables as mean ± SD. To assess the association between MetS components and DII as a response 
variable, linear regression was used and adjusted odds of MetS and its component by DII normal quartiles were 
investigated via logistic regression models. Finally, the separate effect of each MetS component on DII quartiles 
was investigated via multinomial logistic regression. All the statistical analysis performed in SPSS 19.0 software 
and P < 0.05 was considered as statistically significant.
Ethics approval and consent to participate. The study protocol was following the Helsinki Declaration 
and was confirmed by the Ethics Committee of Fasa University of Medical Sciences (Approval Code: IR.FUMS.
REC.1395.177). The participants were informed about the research objectives and the written informed consent 
was obtained from the subjects before starting the survey.
Consent for publication. Not applicable.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on 
reasonable request to the corresponding author.
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